WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2014

Jun 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-05-29

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-29	Common Stock	M	2000.0000	$21.3400	Acquired	25933.9500	Direct
2014-05-29	Common Stock	S	2000.0000	$43.0000	Disposed	23933.9500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-29	Stock Option (Right to Buy)	$21.3400	M	2000.0000	Disposed	2020-03-22	Common Stock (2000.0000)	Direct

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.